Timothy C. Barabe, Director at Opexa Therapeutics, Inc. (OPXA), bought 10,000 shares at $1.15 ($12K) on 2014-09-17, disclosed to the SEC on 2014-09-18.
Open-market purchase of $12k OPXA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SELB | BUY | 2022-05-11 | $39K | — | Filing → |
| SELB | BUY | 2021-08-20 | $36K | — | Filing → |
| SELB | BUY | 2021-03-30 | $41K | — | Filing → |